Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma Cells

por Vella, Serena, Tavanti, Elisa, Hattinger, Claudia Maria, Fanelli, Marilù, Versteeg, Rogier, Koster, Jan, Picci, Piero, Serra, Massimo
Publicado 2016

Cisplatin Resistance in Osteosarcoma: In vitro Validation of Candidate DNA Repair-Related Therapeutic Targets and Drugs for Tailored Treatments

por Fanelli, Marilù, Tavanti, Elisa, Patrizio, Maria Pia, Vella, Serena, Fernandez-Ramos, Amira, Magagnoli, Federica, Luppi, Silvia, Hattinger, Claudia Maria, Serra, Massimo
Publicado 2020

Targeting Glutathione-S Transferase Enzymes in Musculoskeletal Sarcomas: A Promising Therapeutic Strategy

por Pasello, Michela, Manara, Maria Cristina, Michelacci, Francesca, Fanelli, Marilù, Hattinger, Claudia Maria, Nicoletti, Giordano, Landuzzi, Lorena, Lollini, Pier Luigi, Caccuri, Annamaria, Picci, Piero, Scotlandi, Katia, Serra, Massimo
Publicado 2011

Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-meta...

por Hattinger, Claudia M., Biason, Paola, Iacoboni, Erika, Gagno, Sara, Fanelli, Marilù, Tavanti, Elisa, Vella, Serena, Ferrari, Stefano, Roli, Andrea, Roncato, Rossana, Giodini, Luciana, Scotlandi, Katia, Picci, Piero, Toffoli, Giuseppe, Serra, Massimo
Publicado 2016